. . . . . . . . . . . . "[Loss of heterozygosity of p16 correlates with minimal residual disease at the end of the induction therapy in non-high risk childhood B-cell precursor acute lymphoblastic leukemia/of p16 may be a marker of chemotherapy resistance in BCP-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:43:15+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .